Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1324-1330

  Tenover, Fred C ^a   Tickler, Isabella A ^a   Goering, Richard V ^b   Kreiswirth, Barry N ^c   Mediavilla, José R ^c   Persinga, David H ^a  

^a CEPHEID   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; PSEUDOMONIC ACID; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CASSETTE; GENE SEQUENCE; HOSPITAL; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CLINDAMYCIN; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; NASAL CAVITY; PREVALENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TOBRAMYCIN; UNITED STATES;

EID: 84857158986     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05804-11     Document Type: Article

References (51)

1. Anthony RM, Connor AM, Power EG, French GL. 1999. Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 18: 30-34. (Pubitemid 29531150)
2. Arias CA, et al. 2008. MRSA USA300 clone and VREF-a U.S.-Colombian connection? N. Engl. J. Med. 359:2177-2179.
3. Bannerman TL, Peacock SJ. 2007. Staphylococcus, Micrococcus, and other catalase-positive cocci, p 390-411. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
4. Benson G. 1997. Sequence alignment with tandem duplication. J. Comput. Biol. 4:351-367. (Pubitemid 27355873)
5. Calfee DP, et al. 2008. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S62-S80.
6. Chavez-Bueno S, et al. 2005. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49:2283-2288. (Pubitemid 40734455)
7. Chen L, et al. 2009. Multiplex real-time PCR for rapid Staphylococcal cassette chromosome mec typing. J. Clin. Microbiol. 47:3692-3706.
8. Chung M, Dickinson G, De Lencastre H, Tomasz A. 2004. International clones of methicillin-resistant Staphylococcus aureus in two hospitals in Miami, Florida. J. Clin. Microbiol. 42:542-547. (Pubitemid 38222626)
9. Clinical Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed., M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Clinical Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, 21st informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
11. D'Agata EM, Webb GF, Horn MA, Moellering RC, Jr, Ruan S. 2009. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin. Infect. Dis. 48:274-284.
12. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568.
13. Diep BA, et al. 2008. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148:249-257. (Pubitemid 351665484)
14. Diep BA, et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739. (Pubitemid 43326291)
15. Diep BA, et al. 2008. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 197:1523-1530. (Pubitemid 351706482)
16. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015. (Pubitemid 30140551)
17. Freitas EA, Harris RM, Blake RK, Salgado CD. 2010. Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance. Infect. Control Hosp. Epidemiol. 31:469-475.
18. Fridkin SK, et al. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
19. Gilbert M, et al. 2007. Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. Can. J. Infect. Dis. Med. Microbiol. 18:357-362. (Pubitemid 351251339)
20. Goering RV, et al. 2008. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J. Clin. Microbiol. 46:2842-2847.
21. Golding GR, et al. 2008. A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Can. J. Infect. Dis. Med. Microbiol. 19:273-281.
22. Gorwitz RJ, et al. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis. 197:1226-1234. (Pubitemid 351632753)
23. Gottlieb T, Su WY, Merlino J, Cheong EY. 2008. Recognition of USA300 isolates of community-acquired methicillin-resistant Staphylococcus aureus in Australia. Med. J. Aust. 189:179-180.
24. Grundmann H, et al. 2010. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 7:e1000215.
25. Han LL, et al. 2007. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J. Clin. Microbiol. 45:1350-1352. (Pubitemid 46626515)
26. Harmsen D, et al. 2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41: 5442-5448. (Pubitemid 37543228)
27. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). 2009. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob. Agents Chemother. 53: 4961-4967.
28. Kaplan SL. 2005. Osteomyelitis in children. Infect. Dis. Clin. North Am. 19:787-797. (Pubitemid 41627490)
29. Klevens RM, et al. 2006. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12: 1991-1993. (Pubitemid 44904946)
30. Klevens RM, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
31. Larsen A, Stegger M, Goering R, Sorum M, Skov R. 2007. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill. 12:2.
32. Limbago B, et al. 2009. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J. Clin. Microbiol. 47:1344-1351.
33. McDougal LK, et al. 2010. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob. Agents Chemother. 54:3804-3811.
34. McDougal LK, et al. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120. (Pubitemid 37429924)
35. Moran GJ, et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
36. Murchan S, et al. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:1574-1585. (Pubitemid 36428107)
37. Nübel U, et al. 2008. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 105:14130-14135.
38. Richter SS, et al. 2011. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob. Agents Chemother. 55:4154-4160.
39. Robinson DA, Enright MC. 2004. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 10:92-97. (Pubitemid 38256512)
40. Ruppitsch W, et al. 2007. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill. 12: E071025.1.
41. Saïd-Salim B, et al. 2005. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J. Clin. Microbiol. 43:3373-3379. (Pubitemid 40981350)
42. Seybold U, et al. 2006. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647-656. (Pubitemid 43271378)
43. Shibuya Y, et al. 2008. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J. Infect. Chemother. 14:439-441.
44. Shopsin B, et al. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556-3563. (Pubitemid 29491091)
45. Tattevin P, Diep BA, Jula M, Perdreau-Remington F. 2009. Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility. Emerg. Infect. Dis. 15:953-955.
46. Tenover FC, Goering RV. 2009. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64:441-446.
47. Tenover FC, et al. 2008. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J. Clin. Microbiol. 46:2837-2841.
48. Tenover FC, et al. 2011. Activity of ACHN-490 against methicillin-resistant Staphylococcus aureus isolates from patients in U.S. hospitals. International J. Antimicrob. Agents 38:352-354.
49. Tenover FC, et al. 2007. Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci. J. Clin. Microbiol. 45:2917-2922. (Pubitemid 47417334)
50. Valentini P, et al. 2008. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann. Clin. Microbiol. Antimicrob. 7:11.
51. Zhang K, McClure JA, Elsayed S, Conly JM. 2009. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:531-540.